You are here: Industry Insights > SARS-CoV-2

News List

Positive early data from siltuximab COVID-19 trial pharmatimes
April 02, 2020
A third of patients with COVID-19 taking EUSA Pharma's interleukin (IL)-6 targeted monoclonal antibody siltuximab have experienced a clinical improvement, according to early findings from an observational case-control trial in Italy.
Beckman Coulter Announces Test Development for Coronavirus Antibodies americanpharmaceuticalreview
April 02, 2020
In response to the global COVID-19 pandemic, Beckman Coulter is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2.
Luminex Receives EUA for NxTAG® CoV Extended Panel to Detect SARS-CoV-2 americanpharmaceuticalreview
April 01, 2020
Luminex announced the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its NxTAG® CoV Extended Panel.
Primmune Selects SARS-CoV-2 Clinical Candidate contractpharma
April 01, 2020
Demonstrates sustained dose-dependent innate immune induction in vivo without the production of inflammatory cytokines.
Sanofi, Translate Bio to develop novel mRNA vaccine for COVID-19 disease pharmaceutical-business-review
March 31, 2020
Sanofi’s vaccines global business unit Sanofi Pasteur has collaborated with Translate Bio for the development of a novel messenger RNA (mRNA) vaccine for COVID-19, the disease resulted due to the novel coronavirus SARS-CoV-2.
Eurofins Launches Coronavirus Testing Solutions contractpharma
March 31, 2020
Eurofins Technologies has launched GeneScan VIRSeek SARS-CoV-2 RT-PCR, an integrated solution including RNA extraction and test kits based on real-time RT-PCR (Reverse transcription polymerase chain reaction) for the detection of SARS-CoV-2 in swabs of en
Nafamostat is expected to prevent the transmission of new coronavirus infection (COVID-19) worldpharmanews
March 31, 2020
Nafamostat mesylate (brand name: Fusan), which is the drug used to treat acute pancreatitis, may effectively block the requisite viral entry process the new coronavirus (SARS-CoV-2) uses to spread and cause disease (COVID-19). The University of Tokyo anno
Sartorius Supports Development of Vaccine Candidate against Coronavirus americanpharmaceuticalreview
March 30, 2020
Sartorius has supported CanSino Biologics and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences ...
Italian Researchers Identify New SARS-CoV-2 Gene Variants americanpharmaceuticalreview
March 30, 2020
Two teams of infectious disease researchers in Italy say they have further analyzed the SARS-CoV-2 genome from samples acquired locally to generate early data.
BGI Genomics Receives EUA for SARS-CoV-2 Test Kit contractpharma
March 30, 2020
Test can return results within three hours and is intended for the qualitative detection of the virus that causes COVID-19 disease.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page